The pivotal event in the pathophysiology of IgA nephropathy is the binding of circulating IgA-
containing immune complexes to mesangial cells, with secondary glomerular and …

IgA nephropathy (IgAN) is the most common glomerular disease in the world. However, the
approach to treatment remains controversial. There has been an explosion of clinical trials …

IgA nephropathy (IgAN) is the most common type of glomerulonephritis in Asia and the
Western world. In most patients, it follows an asymptomatic to oligosymptomatic course and …

IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide.
Recently, there have been multiple advances in the understanding of IgAN pathophysiology …

IgA nephropathy remains the most common primary glomerular disease worldwide. It affects
children and adults of all ages, and is a leading cause of end-stage kidney disease, making …

IgA nephropathy is the most common form of primary glomerulonephritis in the world and is
also the most common cause of end-stage renal disease in patients with primary …

IgA nephropathy (IgAN), the most prevalent primary glomerulonephritis worldwide, carries a
considerable lifetime risk of kidney failure. Clinical manifestations of IgAN vary from …

Immunoglobulin A nephropathy (IgAN) is the most common primary form of glomerular
disease worldwide and carries a high lifetime risk of kidney failure. The underlying …

International endeavors to improve the outcome of patients with IgA nephropathy have
produced evidencebased treatment recommendations and inspired efforts to develop novel …

IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide,
exhibiting a variable clinical and pathological course and significantly contributing to the …